International Registry iBIOGEAS (31-07-07)
Data on each Biologic Agent
- Infliximab (516 patients)
- Rituximab (286 patients)
- Etanercept (258 patients)
- Anakinra (13 patients)
- Adalimumab (8 patients)
- Epratuzumab (14 patients)
- Efalizumab (13 patients)
- Alemtuzumab (1 patients)
- Ocrelizumab (1 patients)